Heparin for RAO Post-Transradial Angiography in AIS
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.
Also called NCT07162064
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 440 participants
- Sponsor
- Registry
-
NCT07162064
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07162064. Randomized; double masking; primary purpose prevention. Start 2025-08-04 (actual); primary completion 2026-01-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Heparin for RAO Post-Transradial Angiography in AIS
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Heparin - Therapeutic dosage
- Intervention (Drug)
- Saline (0.9% NaCl)
- Lead sponsor
- Xiang Luo
Record details
- Record id
cardio:ct-nct07162064- Content hash
d27845c32c605bc70984334d1b96f03295d88c926fe02ca586237b6936cbb075